BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 25749935)

  • 1. Gut microbiota: a key player in health and disease. A review focused on obesity.
    Villanueva-Millán MJ; Pérez-Matute P; Oteo JA
    J Physiol Biochem; 2015 Sep; 71(3):509-25. PubMed ID: 25749935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood obesity: a role for gut microbiota?
    Sanchez M; Panahi S; Tremblay A
    Int J Environ Res Public Health; 2014 Dec; 12(1):162-75. PubMed ID: 25546278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
    Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
    Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota composition and its effects on obesity and insulin resistance.
    Caricilli AM; Saad MJ
    Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crosstalk between gut microbiota and obesity and related metabolic disorders.
    Xu WT; Nie YZ; Yang Z; Lu NH
    Future Microbiol; 2016 Jun; 11():825-36. PubMed ID: 27192213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome approaches to treat obesity in humans.
    Bianchi F; Duque ALRF; Saad SMI; Sivieri K
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the gut microbiota in metabolic health.
    Janssen AW; Kersten S
    FASEB J; 2015 Aug; 29(8):3111-23. PubMed ID: 25921831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.